Navigation Links
ADHD Drugs Didn't Raise Heart Risks for Kids, Study Finds

FRIDAY, Nov. 2 (HealthDay News) -- Children who take drugs to treat attention-deficit/hyperactivity disorder (ADHD) are not at increased risk for serious heart problems, according to a new review that confirms previous findings.

University of Florida researchers analyzed data from 1.2 million U.S. youths in Medicaid programs in 28 states, and found that the per-year risk of any child suffering a severe cardiac event was about one in 30,000. Severe cardiac events include sudden cardiac death, heart attack and stroke, and are typically caused by underlying heart disease.

Children taking ADHD drugs such as Adderall and Ritalin did not have a greater risk of severe cardiac events than other children, according to the study published recently in the British Medical Journal.

The results confirm previous studies that concluded that the use of such stimulants by children and young adults does not increase the short-term risk of serious heart problems.

"This is a question that has been lingering for about 10 years," study author Almut Winterstein, a pharmacoepidemiologist and a professor in pharmaceutical outcomes and policy in the UF College of Pharmacy, said in a university news release.

She noted that stimulants are the third most commonly prescribed medications for children, after antibiotics and antidepressants.

While this and previous studies concluded that use of ADHD drugs poses no short-term risk to heart health, the long-term effects still aren't known.

"It's an important issue to address, but we won't be able to answer the question until this generation of ADHD children, who began using stimulant drugs in the 1990s, reaches adulthood into their 50s, 60s and 70s," Winterstein said.

More information

The U.S. National Institute of Mental Health has more about attention-deficit/hyperactivity disorder.

-- Robert Preidt

SOURCE: University of Florida, news release, Oct. 31, 2012

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. The cost of prescription drugs -- a comparison of 2 countries
2. Study: Use of antipsychotic drugs improves life expectancy for individuals with schizophrenia
3. UGA researchers boost efficacy of drugs by using nanoparticles to target powerhouse of cells
4. New test to crack down on sporting drugs-cheat test
5. Under-twisted DNA origami delivers cancer drugs to tumors
6. Mutation breaks HIVs resistance to drugs
7. When Prescription Drugs Go OTC, Ads Talk Less of Harms: Study
8. Some Blood Pressure Drugs Might Help Slow Alzheimers: Study
9. Improved nanoparticles deliver drugs into brain
10. More Pregnant Women on Blood Pressure Drugs: Study
11. Most prescription drugs manufactured overseas -- are they safe?
Post Your Comments:
Related Image:
ADHD Drugs Didn't Raise Heart Risks for Kids, Study Finds
(Date:12/1/2015)... ... December 01, 2015 , ... Lutronic, a leading innovator ... the latest addition to the devices for sale in the United States. Clarity ... and long-pulsed 1064 nm Nd:YAG lasers, into a single platform that is easy to ...
(Date:12/1/2015)... CA (PRWEB) , ... December 01, 2015 , ... ... has selected 10 semi-finalists to head to Las Vegas for CES 2016, the world’s ... including CEO of Consumer Technology Association Gary Shapiro, Founding Partner of Pacific Investments Veronica ...
(Date:12/1/2015)... ... 2015 , ... Nurotron Biotechnology Co., Ltd., maker of cochlear implant systems, has ... The order will be from the China Disabled Persons’ Federation, a central government association, ... solution for children and adults suffering from severe and profound hearing loss . ...
(Date:12/1/2015)... ... December 01, 2015 , ... Tympani Inc., announced ... (ATP) status from Cisco. This designation recognizes Tympani as having fulfilled the training ... solutions targeted to the high-end enterprise contact center marketplace. , Ed Kapelinski, President ...
(Date:11/30/2015)... , ... November 30, 2015 , ... Trevor and Taylor ... as they play for the chance to represent the United States. This hybrid ... to be a part of their journey in addition to offering corporate sponsors with ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... Sweden , December 1, 2015 ... Cancer Study Group (IBCSG, Bern ) and ... to be part of a state of the art trial, ... --> --> The study, ... treated with anti-hormonal therapy in combination with palbociclib, a cancer ...
(Date:11/30/2015)... BASEL, Switzerland , Dec. 1, 2015 ... through its wholly-owned UK subsidiary Proximagen Ltd., today announced ... novel, oral small molecule inhibitor of Vascular Adhesion Protein ... in the treatment of inflammatory disease. The VAP-1 inhibitor ... --> --> Under the terms ...
(Date:11/30/2015)... Asia,s largest exhibition and conference dedicated to the Medical Device ... 22 nd April 2016. --> --> ... --> -->   --> --> ... population and the government back up, the Medical Device is one of the ... . With the aging population and the government back up, the Medical ...
Breaking Medicine Technology: